Your browser doesn't support javascript.
loading
The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
Awiwi, Muhammad O; Elsayes, Khaled M; Mohamed, Yehia I; Altameemi, Lina; Gjoni, Migena; Irshad, Omayr Muhammad; Sayed Ahmed, Ahmed; Kaseb, Ahmad O; Salem, Usama.
Afiliación
  • Awiwi MO; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Elsayes KM; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mohamed YI; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Altameemi L; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gjoni M; Department of Internal Medicine, The of Istanbul-Cerrahpasa Hospital, Istanbul, Turkey.
  • Irshad OM; John Sealy School of Medicine, Galveston, TX, USA.
  • Sayed Ahmed A; Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kaseb AO; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Salem U; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J Hepatocell Carcinoma ; 9: 913-927, 2022.
Article en En | MEDLINE | ID: mdl-36065424

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Hepatocell Carcinoma Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Hepatocell Carcinoma Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...